GlycoMimetics (GLYC) Short Interest Ratio & Short Volume $0.23 +0.03 (+13.82%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GlycoMimetics Short Interest DataGlycoMimetics (GLYC) has a short interest of 2.60 million shares. This marks a -31.58% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 6.61 million shares to cover all short positions.Current Short Interest2,600,000 sharesPrevious Short Interest3,800,000 sharesChange Vs. Previous Month-31.58%Dollar Volume Sold Short$901,940.00Short Interest Ratio0.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares64,484,000 sharesPercentage of Shares Shorted4.03%Today's Trading Volume1,034,578 sharesAverage Trading Volume6,609,521 sharesToday's Volume Vs. Average16% Short Selling GlycoMimetics? Sign up to receive the latest short interest report for GlycoMimetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLYC Short Interest Over TimeGLYC Days to Cover Over TimeGLYC Percentage of Float Shorted Over Time Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. GlycoMimetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20242,600,000 shares $901,940.00 -31.6%N/A0.1 $0.35 11/15/20243,800,000 shares $1.58 million -32.6%N/A0.2 $0.42 10/31/20245,640,000 shares $2.29 million +208.2%N/A0.3 $0.41 10/15/20241,830,000 shares $278,892.00 +11.6%N/A1.6 $0.15 9/30/20241,640,000 shares $277,160.00 -9.9%N/A1.5 $0.17 9/15/20241,820,000 shares $309,400.00 -5.7%N/A0.5 $0.17 Get the Latest News and Ratings for GLYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GlycoMimetics and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,930,000 shares $340,259.00 -16.5%N/A0.5 $0.18 8/15/20242,310,000 shares $413,952.00 -25.7%N/A0.6 $0.18 7/31/20243,110,000 shares $674,870.00 +9.1%N/A0.8 $0.22 7/15/20242,850,000 shares $883,500.00 -44.2%N/A0.7 $0.31 6/30/20245,110,000 shares $1.44 million +190.3%N/A1.2 $0.28 6/15/20241,760,000 shares $462,880.00 -15.8%N/A0.4 $0.26 5/31/20242,090,000 shares $566,390.00 -10.7%N/A1.2 $0.27 5/15/20242,340,000 shares $631,800.00 -61.6%N/A1.5 $0.27 4/30/20246,090,000 shares $10.96 million +102.3%N/A4.6 $1.80 4/15/20243,010,000 shares $6.79 million +89.3%N/A6.6 $2.26 3/31/20241,590,000 shares $4.77 million +6.7%N/A4.3 $3.00 3/15/20241,490,000 shares $3.81 million -4.5%N/A4.2 $2.56 2/29/20241,560,000 shares $4.51 million +9.1%N/A4.6 $2.89 2/15/20241,430,000 shares $4.42 million +43.3%N/A4.5 $3.09 1/31/2024997,900 shares $2.99 million +24.8%N/A3.5 $3.00 1/15/2024799,700 shares $2.49 million +40.3%N/A3.3 $3.11 12/31/2023570,000 shares $1.35 million -11.2%N/A2.9 $2.36 12/15/2023641,600 shares $1.27 million -23.7%N/A3.8 $1.98 11/30/2023841,200 shares $1.38 million -4.3%N/A7 $1.64 11/15/2023878,900 shares $1.22 million -1.6%N/A7.5 $1.39 10/31/2023893,500 shares $1.12 million -8.9%N/A7.3 $1.25 10/15/2023981,100 shares $1.39 million +4.3%N/A8.1 $1.42 9/30/2023940,300 shares $1.41 million -7.8%N/A8.2 $1.50 9/15/20231,020,000 shares $1.44 million -1.9%N/A8.8 $1.41 8/31/20231,040,000 shares $1.66 million -6.3%N/A7.6 $1.60 8/15/20231,110,000 shares $1.78 million -4.3%N/A6.6 $1.60 7/31/20231,160,000 shares $1.90 million -4.9%N/A5.1 $1.64 7/15/20231,220,000 shares $2.01 million -1.6%N/A5.2 $1.65 6/30/20231,240,000 shares $2.16 million +1.6%N/A5.1 $1.74 6/15/20231,220,000 shares $2.33 million -14.1%N/A4.3 $1.91 5/31/20231,420,000 shares $2.64 million +7.6%N/A4.5 $1.86 5/15/20231,320,000 shares $2.75 million -2.2%N/A2.8 $2.08 4/30/20231,350,000 shares $1.89 million -13.5%N/A1.3 $1.40 4/15/20231,560,000 shares $2.29 million -23.5%N/A1.2 $1.47URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin 3/31/20232,040,000 shares $2.57 million -0.5%N/A1.5 $1.26 3/15/20232,050,000 shares $3.05 million -23.5%4.5%1.4 $1.49 2/28/20232,680,000 shares $4.13 million +92.8%5.8%1.8 $1.54 2/15/20231,390,000 shares $2.11 million +40.0%3.0%1 $1.52 1/31/2023992,600 shares $2.89 million +50.2%2.2%1 $2.91 1/15/2023660,700 shares $2.00 million +7.8%1.6%1 $3.02 12/30/2022613,000 shares $1.86 million +20.8%1.5%1.1 $3.03 12/15/2022507,300 shares $1.03 million -0.6%1.2%1.2 $2.04 11/30/2022510,200 shares $1.10 million -14.2%1.2%1.4 $2.16 11/15/2022594,500 shares $1.01 million +3.6%1.4%1.9 $1.70 10/31/2022574,100 shares $389,412.03 +19.7%1.4%5.1 $0.68 10/15/2022479,700 shares $298,133.55 +2.4%1.1%3.9 $0.62 9/30/2022468,700 shares $258,581.79 -5.8%1.1%3.6 $0.55 9/15/2022497,300 shares $341,098.07 -1.8%1.2%3.7 $0.69 8/31/2022506,300 shares $384,788.00 +6.1%1.2%3.5 $0.76 8/15/2022477,300 shares $400,932.00 -10.9%1.1%3.5 $0.84 7/31/2022535,500 shares $355,036.50 -6.8%1.6%3.6 $0.66 7/15/2022574,500 shares $363,141.45 +4.3%1.7%3.4 $0.63 6/30/2022551,000 shares $329,442.90 -17.1%1.7%3.1 $0.60 6/15/2022664,400 shares $372,794.84 +2.3%2.0%3.7 $0.56 5/31/2022649,500 shares $432,437.10 +5.8%1.5%3.7 $0.67 5/15/2022613,700 shares $346,126.80 -2.3%1.5%3.1 $0.56 4/30/2022628,300 shares $451,496.38 +3.9%1.5%3 $0.72 4/15/2022605,000 shares $605,000.00 -1.1%1.4%3 $1.00 3/31/2022612,000 shares $697,680.00 -2.3%1.5%2.9 $1.14 3/15/2022626,400 shares $645,192.00 -8.9%1.5%2.6 $1.03 2/28/2022687,600 shares $845,748.00 +1.3%1.7%2.6 $1.23 2/15/2022678,600 shares $719,316.00 -10.1%1.6%2.4 $1.06 1/31/2022754,700 shares $898,093.00 +13.5%1.8%2.4 $1.19 1/15/2022665,200 shares $824,848.00 +1.2%N/A2 $1.24 12/31/2021657,600 shares $946,944.00 -2.7%1.6%1.9 $1.44 12/15/2021676,000 shares $1.03 million +1.8%1.6%1.1 $1.52 11/30/2021664,300 shares $1.12 million -10.2%1.6%1 $1.69 11/15/2021739,400 shares $1.58 million -0.5%1.8%1.1 $2.14 10/29/2021743,300 shares $1.42 million -12.7%1.8%1.2 $1.91 10/15/2021851,000 shares $1.68 million -21.9%2.1%1.3 $1.98 9/30/20211,090,000 shares $2.39 million +1.9%2.6%1.7 $2.19 9/15/20211,070,000 shares $2.29 million -2.7%2.6%2.1 $2.14 8/31/20211,100,000 shares $2.44 million -28.6%2.7%2.4 $2.22 8/13/20211,540,000 shares $3.05 million -6.7%3.7%3.2 $1.98 7/30/20211,650,000 shares $3.33 million No Change4.0%2.4 $2.02 7/15/20211,650,000 shares $3.35 million +7.1%4.0%2.3 $2.03 6/30/20211,540,000 shares $3.57 million -37.1%3.7%1.9 $2.32 6/15/20212,450,000 shares $6.32 million -11.6%5.9%3.2 $2.58 5/28/20212,770,000 shares $7.06 million +26.5%6.7%3.5 $2.55 5/14/20212,190,000 shares $5.52 million -11.0%5.3%2.4 $2.52 4/30/20212,460,000 shares $6.15 million +74.5%6.0%3 $2.50 4/15/20211,410,000 shares $3.71 million +6.8%3.4%1.6 $2.63 3/31/20211,320,000 shares $3.83 million +3.9%3.2%1.5 $2.90 3/15/20211,270,000 shares $4.20 million +18.7%3.2%1.5 $3.31URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin 2/26/20211,070,000 shares $3.66 million +16.4%2.7%1.3 $3.42 2/12/2021919,100 shares $3.74 million +4.6%2.5%1.2 $4.07 1/29/2021878,800 shares $3.22 million -2.9%2.3%1.2 $3.66 1/15/2021904,700 shares $3.40 million -54.3%2.4%1.3 $3.76 12/31/20201,980,000 shares $7.50 million -21.7%5.3%3.2 $3.79 12/15/20202,530,000 shares $9.21 million +36.0%6.7%4.3 $3.64 11/30/20201,860,000 shares $6.81 million -5.6%4.9%3.7 $3.66 11/15/20201,970,000 shares $6.88 million +1.0%5.2%4.7 $3.49 10/30/20201,950,000 shares $5.62 million -11.4%5.2%5.6 $2.88 10/15/20202,200,000 shares $7.55 million +8.9%5.8%7.4 $3.43 9/30/20202,020,000 shares $6.20 million -5.6%5.4%5.2 $3.07 9/15/20202,140,000 shares $7.62 million -0.5%5.7%4.2 $3.56 8/31/20202,150,000 shares $7.93 million -2.7%5.7%2.8 $3.69 8/14/20202,210,000 shares $8.18 million -3.5%6.0%2.8 $3.70 7/31/20202,290,000 shares $9.02 million -7.7%6.2%2.9 $3.94 7/15/20202,480,000 shares $9.94 million -11.1%7.4%3.3 $4.01 6/30/20202,790,000 shares $10.49 million +4.5%8.3%4.1 $3.76 6/15/20202,670,000 shares $8.09 million -0.4%8.0%4.8 $3.03 5/29/20202,680,000 shares $7.58 million -0.7%8.0%8 $2.83 5/15/20202,700,000 shares $8.40 million -3.2%8.1%8.5 $3.11 4/30/20202,790,000 shares $7.78 million -3.1%8.3%9.9 $2.79 4/15/20202,880,000 shares $7.43 million -6.8%8.6%11.2 $2.58 3/31/20203,090,000 shares $7.73 million -4.6%9.2%12.1 $2.50 3/13/20203,240,300 shares $8.62 million +0.9%9.7%15.9 $2.66 2/28/20203,210,000 shares $6.90 million +0.6%9.6%15.4 $2.15 2/14/20203,190,000 shares $9.89 million -4.8%9.6%14.4 $3.10 1/31/20203,350,000 shares $12.26 million +3.1%10.1%13.9 $3.66 1/15/20203,250,000 shares $14.17 million -1.5%9.8%13.1 $4.36 12/31/20193,300,000 shares $15.05 million +0.9%9.9%13.3 $4.56 GLYC Short Interest - Frequently Asked Questions What is GlycoMimetics' current short interest? Short interest is the volume of GlycoMimetics shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 2,600,000 shares of GLYC short. Learn More on GlycoMimetics' current short interest. Which institutional investors are shorting GlycoMimetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GlycoMimetics: LMR Partners LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is GlycoMimetics' short interest increasing or decreasing? GlycoMimetics saw a decrease in short interest in the month of November. As of November 30th, there was short interest totaling 2,600,000 shares, a decrease of 31.6% from the previous total of 3,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does GlycoMimetics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GlycoMimetics: BeyondSpring Inc. (8.38%), Atara Biotherapeutics, Inc. (12.95%), Connect Biopharma Holdings Limited (0.11%), Spero Therapeutics, Inc. (0.91%), Mural Oncology plc (3.07%), Aadi Bioscience, Inc. (1.11%), Invivyd, Inc. (6.60%), Kronos Bio, Inc. (1.30%), Immix Biopharma, Inc. (2.87%), Immuneering Co. (7.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short GlycoMimetics stock? Short selling GLYC is an investing strategy that aims to generate trading profit from GlycoMimetics as its price is falling. GLYC shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GlycoMimetics? A short squeeze for GlycoMimetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLYC, which in turn drives the price of the stock up even further. How often is GlycoMimetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLYC, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies BeyondSpring Short Interest Atara Biotherapeutics Short Interest Connect Biopharma Short Interest Spero Therapeutics Short Interest Mural Oncology Short Interest Aadi Bioscience Short Interest Invivyd Short Interest Kronos Bio Short Interest Immix Biopharma Short Interest Immuneering Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLYC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
